22nd Century Group, Inc. (NYSE MKT: XXII) today announced that the Company filed its third quarter 2014 report on Form 10-Q with the U.S. Securities and Exchange Commission.
Recent Business Highlights
•22nd Century engaged a major contract research organization (“CRO”) with extensive experience in tobacco exposure studies to assist the Company in certain regulatory activities at the Center for Tobacco Products (“CTP”) of the U.S. Food and Drug Administration (“FDA”) related to the Company’s research to support the development of potentially less harmful or modified risk cigarettes.
Help employers find you! Check out all the jobs and post your resume.
